Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study
CONCLUSIONS: This study first reported that anlotinib combined with Stupp regimen is a safe and feasible regimen for newly diagnosed patients with H3K27M-DMG. Further, anlotinib showed significant efficacy for H3K27M-DMG located in the infratentorial region.PMID:38644565 | PMC:PMC11033330 | DOI:10.1111/cns.14730
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Chao Liu Shuwen Kuang Tianxiang Huang Jun Wu Longbo Zhang Xuan Gong Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Glioma | Neurology | Neuroscience | Study | Temodar | Toxicology